This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Vance Hayden Thomas: Innovator in Pharmaceutical Compositions
Introduction
Vance Hayden Thomas is a notable inventor based in Duxbury, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of CFTR mediated diseases. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Vance Hayden Thomas holds a patent for a process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases. This patent, which includes the preparation of compositions comprising 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (Compound 1) in Form I, focuses on methods of treating, lessening the severity of, or symptomatically treating diseases such as cystic fibrosis. The patent also covers methods of administering these compositions and the associated kits.
Career Highlights
Vance Hayden Thomas is currently associated with Vertex Pharmaceuticals, Inc., a leading company in the biotechnology sector. His work at Vertex has allowed him to focus on innovative solutions for complex medical challenges. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.
Collaborations
Throughout his career, Vance has collaborated with talented professionals, including Kelly Ann Swinney and Patricia Nell Hurter. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Vance Hayden Thomas exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the treatment of CFTR mediated diseases, highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile